Navios Maritime Partners L.P. Announces the Date for the Release of Third Quarter 2018 Results, Conference Call and Webcast
Conference Call & Webcast: Tuesday, November 13, 2018 at 8:30 am ET MONACO, Nov. 08, 2018 (GLOBE NEWSWIRE) — Navios […]
Bonanza Creek Energy Announces Third Quarter 2018 Financial Results and Operational Update
DENVER, Nov. 08, 2018 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (the “Company” or “Bonanza Creek”) today announced […]
Brink’s Announces Partnership with Canopy Growth
Brink’s to Provide Secure Logistics and Cash Management Services to Canada’s Largest Cannabis Producer RICHMOND, Va., Nov. 08, 2018 (GLOBE […]
Alder BioPharmaceuticals® to Present at Two Upcoming November Investor Conferences
BOTHELL, Wash., Nov. 08, 2018 (GLOBE NEWSWIRE) — Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic […]
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MENLO PARK, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech […]
ICU Medical, Inc. Announces Third Quarter 2018 Results
Company Modifies FY 2018 Guidance and Provides Initial FY 2019 Adjusted EBITDA Guidance SAN CLEMENTE, Calif., Nov. 08, 2018 (GLOBE […]
Altair Announces Third Quarter 2018 Financial Results
Third Quarter Software Product Revenue Increased 13% Year-over-Year TROY, Mich., Nov. 08, 2018 (GLOBE NEWSWIRE) — Altair (Nasdaq:ALTR) released its […]
ATA Reports 2018 Third Quarter Financial Results
Company to Hold Conference Call on Thursday, November 8, 2018, at 8 p.m. ET BEIJING, Nov. 08, 2018 (GLOBE NEWSWIRE) […]
A-Mark Precious Metals Reports Fiscal First Quarter 2019 Results
EL SEGUNDO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK), a leading full-service provider of […]
BioDelivery Sciences Reports Strong Third Quarter 2018 Financial Results
BELBUCA® continued on an accelerated growth trajectory, with revenue increasing 92% YOY and 27% versus prior quarter BELBUCA total prescriptions experienced […]
